Eagle Pharmaceuticals, Inc. Deferred Tax Liabilities, Other
Eagle Pharmaceuticals, Inc. had Deferred Tax Liabilities, Other of $247.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesOther · last filed 2023-03-23
- 2022-12-31: Deferred Tax Liabilities, Other $247.00K.
- 2021-12-31: Deferred Tax Liabilities, Other $0.00.
- 2020-12-31: Deferred Tax Liabilities, Other $0.00.
- 2019-12-31: Deferred Tax Liabilities, Other $0.00.
| Period end | Deferred Tax Liabilities, Other |
|---|---|
| 2022-12-31 | $247.00K 10-K · filed 2023-03-23 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-05 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-05 |
| 2018-12-31 | $91.00K 10-K · filed 2020-03-02 |
| 2017-12-31 | $195.00K 10-K · filed 2019-02-28 |
| 2016-12-31 | $7.00K 10-K · filed 2018-02-26 |
| 2015-12-31 | $7.00K 10-K · filed 2017-03-15 |
| 2014-12-31 | $7.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | $0.00 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 10-K · filed 2016-02-29 |